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a b s t r a c t
The mechanism by which acetaminophen (APAP) causes liver damage evokes many aspects drug
metabolism, oxidative chemistry, and genetic-predisposition. In this study, we leverage the relative
resistance of female C57BL/6 mice to APAP-induced liver damage (AILD) compared to male C57BL/6 mice
in order to identify the cause(s) of sensitivity. Furthermore, we use mice that are either heterozygous
(HZ) or null (KO) for glutamate cysteine ligase modiﬁer subunit (Gclm), in order to titrate the toxicity
relative to wild-type (WT) mice. Gclm is important for efﬁcient de novo synthesis of glutathione (GSH).
APAP (300 mg/kg, ip) or saline was administered and mice were collected at 0, 0.5, 1, 2, 6, 12, and 24 h.
Male mice showed marked elevation in serum alanine aminotransferase by 6 h. In contrast, female WT
and HZ mice showed minimal toxicity at all time points. Female KO mice, however, showed AILD
comparable to male mice. Genotype-matched male and female mice showed comparable APAP–protein
adducts, with Gclm KO mice sustaining signiﬁcantly greater adducts. ATP was depleted in mice showing
toxicity, suggesting impaired mitochondria function. Indeed, peroxiredoxin-6, a GSH-dependent perox-
iredoxin, was preferentially adducted by APAP in mitochondria of male mice but rarely adducted in
female mice. These results support parallel mechanisms of toxicity where APAP adduction of
peroxiredoxin-6 and sustained GSH depletion results in the collapse of mitochondria function and
hepatocyte death. We conclude that adduction of peroxiredoxin-6 sensitizes male C57BL/6 mice to
toxicity by acetaminophen.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Acute acetaminophen (APAP) overdose in mice and humans
causes centrilobular necrosis in the liver within hours. A large
number of studies have provided a thorough understanding of the
metabolism and associated toxicity of APAP [see [20,22] for recent
reviews]. However, recent studies contrasting the toxicity of APAP
to its regio-isomer N-acetyl-meta-aminophenol (AMAP) in mouse,
rat and human liver slices, demonstrate that parallel mechanisms
of toxicity may confound our understanding of APAP-induced liver
damage (AILD) [16].
At present, the accepted mechanism of AILD begins with the
saturation and exhaustion of sulfation and glucuronidation path-
ways, which together account for the majority of APAP metabolism
[19]. The oxidation of APAP by cytochrome P-450 (CYP) enzymes
results in the formation of a reactive quinone, N-acetyl-p-
benzoquinoneimine (NAPQI) [11]. NAPQI is the accepted toxic
metabolite of APAP.
NAPQI formation increases with APAP overdose or induction of
CYP-mediated APAP oxidation [35]. NAPQI is inactivated through
glutathione-S-transferase-mediated conjugation to glutathione
(GSH). NAPQI is also non-enzymatically reduced or conjugated
with GSH to form APAP or APAP–glutathione (APAP–SG), respec-
tively [8]. However, sustained NAPQI formation depletes GSH
thereby increasing NAPQI adduction to proteins [9].
Liver damage correlates directly with the level of APAP–protein
adducts in human and animal serum as well as tissue deposition in
animal models [28,32]. Clinically, support of GSH synthesis with
N-acetyl-L-cysteine (NAC) is the standard of care in APAP overdose
[20]. This approach is empirically successful and is supported by
research showing that GSH synthesis is inversely associated with
AILD [4,10,27].
At the cellular level, simultaneous depletion of mitochondrial GSH
and NAPQI adduction of mitochondrial proteins disrupt mitochondrial
function and are closely associated with the formation of the
mitochondrial permeability transition (MPT) pore [3,29]. The forma-
tion of the MPT pore results in the collapse of membrane potential
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and loss of ATP synthesis, and leads to necrosis of the metabolizing
hepatocytes [24]. Further study has shown that a number of mito-
chondrial proteins change expression during AILD and are adducted
by NAPQI [34,37]. It is thought that these changes to the mitochon-
drial proteome reﬂect and support a mechanism of toxicity caused by
oxidative stress and alterations in electron transport.
We, and others, have reported that male mice on the C57BL/6
background display greater sensitivity to AILD than female
mice [4,12,27]. The aim of this study is to identify causal APAP
metabolites and/or protein adducts in order to establish gender-
speciﬁc metabolic pathways relevant to drug toxicity. We geneti-
cally ‘titrated’ APAP-toxicity under constant dosage by using male
and female mice on a C57BL/6J background that are glutamate
cysteine ligase modiﬁer subunit (Gclm) deﬁcient. Gclm KO mice
exhibit compromised synthesis of GSH, and fail to beneﬁt from
NAC-mediated rescue of APAP overdose [27]. Consequently, we
hypothesize that Gclm KO mice should sustain greater protein
adduction and AILD than wild-type mice, regardless of gender.
Here, we present gender-speciﬁc data in support of the hypoth-
esis that APAP toxicity results by at least two parallel mechanisms
leading to mitochondrial dysfunction. Consistent with prior studies,
lack of Gclm predisposes otherwise resistant female mice to
enhanced protein adducts and AILD. This clearly illustrates the
importance of de novo GSH synthesis to protect against APAP toxicity.
Interestingly, male mice, regardless of Gclm genotype, were univer-
sally susceptible to AILD. Contrasting male and female mice, we have
identiﬁed the adduction of mitochondrial peroxiredoxin-6 as a likely
mechanism of mitochondrial dysfunction and cell death. Importantly,
the lack of this adduct in female Gclm KO mice suggests that an
additional mechanism of mitochondrial dysfunction results from
sustained mitochondrial GSH depletion.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich (St. Louis,
MO), unless otherwise indicated.
Mice
All mouse experiments were approved by the University of
Washington Institutional Animal Care and Use Committee. Gclm KO
mice were generated and genotyped as previously described [27].
Mice were housed as sex-matched littermates under controlled light
(6 AM)/dark (6 PM) cycle, and given free access to rodent chow
(LabDiets 5053 PicoLabs Rodent Diet 20, Animal Specialties, Wood-
burn, OR) and acidiﬁed water until experimentation.
For experiments, food was withdrawn for 12 h prior to dosing.
Between 8 and 9 AM, mice were either euthanized (0-h controls)
or dosed (ip) with either sterile 0.9% saline solution (Baxter,
Deerﬁeld, IL) at 10 μl/g BW (vehicle control); or with APAP
dissolved in sterile saline at doses of 150, 300, or 500 mg/kg BW.
APAP was dissolved and held at 60 1C until injection. Injection
volumes were 10 μl/g BW, except for the 500 mg/kg APAP group,
which was 16.7 μl/g BW. Immediately following dosing, food was
returned to the mice.
Tissue collection
Mice were euthanized by CO2 narcosis followed by cervical
dislocation at the indicated times after treatment. Immediately
thereafter, blood was collected via cardiac puncture for serum ALT
activity measurement according to the manufacturer0s protocol
(Diagnostic Chemicals Limited, Oxford, CT). The right anterior liver
lobe was used for isolation of mitochondria as described below.
The left lobe, right posterior lobe, and right half of the median lobe
were immediately snap frozen in liquid nitrogen for subsequent
analysis of total GSH, APAP metabolites, and APAP adducts.
Mitochondria fractionation
Mitochondria were isolated by differential centrifugation, as
previously described [40]. The right anterior lobe was disrupted
using a Dounce homogenizer on ice in 1.0 mL of mitochondria
isolation buffer (MIB; 200 mM mannitol, 50 mM sucrose, 10 mM
KCl, 1 mM EDTA, 10 mM HEPES, pH 7.4) containing 1X Complete
Protease Inhibitor cocktail (Roche Diagnostics Corp, Indianapolis, IN).
Homogenized samples remained on ice until all samples were
collected. Nuclei and larger cellular debris were separated by low
speed centrifugation at 1000 g at 4 1C for 5 min. Mitochondria were
separated from other smaller cytosolic components by centrifugation
at 10,000 g at 4 1C for 10 min. Mitochondria were washed once in
1 mL MIB, resuspended in 300 μl of MIB, and immediately analyzed
(for function) or subsequently stored at 80 1C. Prior to subsequent
analyses, previously frozen mitochondria were sonicated (Model
W-220 Sonicator with Ultrasonic Microtip, Heat Systems, Inc., Farm-
ingdale, NY) for 15 s on ice to assure complete lysis.
The purity of mitochondria isolated by this protocol was
validated by lactate dehydrogenase (LDH) activity (Promega,
Madison, WI). The presence of cytosolic contaminants in the
mitochondrial preparations was less than 5% of the homogenate
LDH activity. The purity of cytosol was validated by the absence of
cytochrome c oxidase, subunit IV (Cell Signaling Technology
#4844, polyclonal rabbit, 1:5000) using Western blot.
Total GSH determination
Total GSH was quantiﬁed in clariﬁed liver homogenate and
mitochondria lysate using naphthalene 2,3-dicarboxaldehyde
ﬂuorescence, as previously described [38].
ATP determination
ATP was quantiﬁed using a luciferase-based bioluminescence
assay (ATP Determination Kit, Invitrogen, Carlsbad, CA). In brief,
previously frozen cytosolic fractions were standardized to 10 mg total
protein/mL in MIB. Ten microliters of sample were assayed in tripli-
cate by addition of 150 μl luciferase/D-luciferin mix. ATP was quanti-
ﬁed against a standard curve of known concentrations of ATP.
Mitochondrial membrane potential
In a subset of experiments, freshly isolated mitochondria were
standardized to 3 mg total protein/mL in MIB. Relative membrane
potential in 30 mg of total mitochondria normalized by protein mass
was estimated based upon JC-1 dye uptake and aggregate formation
as indicated by the ratio of ﬂuorescence emissions at 590 nm and
530 nm. (Invitrogen, Carlsbad, CA). Functional polarization was
assessed by addition of 10 μM each of pyruvate, malate, and NADPH.
APAP–protein adduct, APAP metabolites, and 3-nitrotyrosine
determination by HPLC
APAP–protein adducts were quantiﬁed as previously described
[4], with modiﬁcation. Frozen liver tissue was homogenized 1:15
(w:v) in 20 mM ammonium acetate (pH 7), centrifuged to pellet
debris, and supernatants used for determining APAP–protein
adducts, 3-nitrotyrosine (3-NT) and APAP metabolites.
For APAP adducts and 3-NT determinations, supernatants were
dialyzed (3500 MWCO Slide-a-lyzer, Fisher Scientiﬁc, Pittsburgh,
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PA) against 20 mM ammonium acetate (pH 7) for 416 h at 4 1C.
Fifty microliters of dialyzed homogenate were added to 150 μl of
20 mM ammonium acetate (pH 7) plus 25 μl of dialyzed protease
(10 mg/mL, Sigma P6911) and digested at 37 1C for 16 h. Digests
were diluted 1:1 in 20% trichloroacetate and centrifuged at
12,000 g at 4 1C for 5 min. Two hundred microliters of super-
natant were diluted 1:1 in 20 mM ammonium acetate (pH 7) and
spiked with 20 μl of 100 μM 7-hydroxycoumarin. Seventy-ﬁve
microliters of the resulting solution were injected for analysis by
HPLC with serial absorbance (λ¼254 nm) and electrochemical
detection (ECD) using a Coularray Detector (ESA, Chelmsford,
MA). Mitochondrial lysate was standardized to 3 mg total pro-
tein/mL and prepared as above, but without dialysis, since no APAP
or APAP metabolites were detectable in the mitochondria.
Metabolites were resolved over a reverse-phase C18 column
(1504.6 mm, 4 mm; Phenomenex, Torrance, CA) under gradient
conditions at a total ﬂow rate of 1.0 mL/min using a Shimadzu SCL-
10A System (Shimadzu Scientiﬁc Instruments, Columbia, MD). The
mobile phase consisted of two solutions; A (20 mM ammonium
acetate, 2% methanol, pH to 4.0 with glacial acetic acid) and B
(20 mM ammonium acetate, 60% methanol, pH to 4.0 with glacial
acetic acid). Gradient separation (in proportion of A over time) was
as follows: (0–3 min) A¼1, (10 min) A¼0.9, (21 min) A¼0.2,
(21.5 min) A¼0, (22 min) A¼0, (27–45 min) A¼1. Metabolites
were identiﬁed using authenticated standards. APAP–glucuronide
and APAP–sulfate were purchased from Synﬁne (Richmond Hill,
Ontario, Canada). APAP–cysteine was generated and identiﬁed as
previously described [4]. Metabolites were quantiﬁed by area
under the curve at the oxidation potentials (AUCox) listed in
Table S1. The absolute amounts APAP and APAP–glucuronide were
determined by standard curve against AUCox. The absolute amount
of APAP–cysteine, APAP–glutathione and APAP–(OH)–SG were
estimated by response factor of each (slope of the absorbance at
254 nm) with the AUCox to the absorbance (λ¼254 nm) multiplied
by the AUCox of APAP at known concentrations.
Generation and validation of 3-nitrotyrosine
3-Nitrotyrosine was generated in biological samples as pre-
viously described [31]. Five microliters of 10 mM peroxynitrite
in 10 mM NaOH (gift of Dr. Joseph Beckman, Oregon State
University), was added to 50 μl of dialyzed liver homogenate in
150 μl of 20 mM ammonium acetate (pH 7) and brieﬂy vortexed.
The solution was incubated at room temperature for 5 min.
Twenty-ﬁve μl of protease solution was added to the sample,
which was then incubated at 37 1C for 16 h. The digested sample
was prepared for HPLC-ECD as described above. The retention time
of the resulting 3-NT peak was validated against 3-NT purchased
from Sigma-Aldrich.
A positive control for immunoblot detection of nitrated mito-
chondrial proteins was generated by the addition of 1 μl of 10 mM
peroxynitrite to 20 μl of mitochondria (3 mg/mL total protein)
isolated from a control female Gclm wild-type (WT) mouse. The
solution was brieﬂy vortexed and incubated at room temperature
for 5 min prior to the addition of 4 sample buffer containing 2%
SDS, 700 mM βmercaptoethanol (SDS/BME).
Immunoblot detection of APAP-adducts and 3-nitrotyrosine
Speciﬁed liver fractions were standardized to total protein
using the Bradford method (Bio-Rad, Hercules, CA) in MIB buffer.
Samples were prepared in SDS/BME buffer, boiled, resolved under
denaturing conditions (24 mM Tris-base, 192 mM glycine, 0.1%
SDS) in 10% polyacrylamide gels and transferred to PVDF mem-
brane (Immobilon-P, Millipore, Billerica, MA) by standard meth-
ods. Membranes were washed in phosphate buffered salineþ0.1%
Tween-20 (PBS-T) then pre-blocked in PBS-Tþ5% non-fat dry milk
(NFDM) powder. Blots were incubated in primary then secondary
antibody suspended in PBSþ0.1% Tween-20 (PBS-T)þ5% NFDM at
the following dilutions: anti-APAP-adduct rabbit sera (gift of Dr.
Lance Pohl, NIH, to Dr. Sidney Nelson, University of Washington;
1:2500), anti-3-nitrotyrosine (Millipore #06-284, polyclonal rab-
bit; 1:2000), anti-mitochondrial cytochrome c oxidase subunit
2 (MT-CO2 or COX2) (Proteintech #55070-1-AP, polyclonal rabbit,
1:5000), anti-glutathione-S-transferase mu1 (Thermo Scientiﬁc
#PIPA522278, polyclonal rabbit, 1:1000), anti-peroxiredoxin-6
(Sigma #AV48267, polyclonal rabbit; 1:1000) and HRP-conjugated
secondary antibody (Millipore #12-348, polyclonal goat; 1:25,000–
1:50,000).
Immunoprecipitation/immunodepletion of Gstm1 and Prdx6
frommitochondria lysate of an APAP-treated male Gclm KO mouse
was analyzed for APAP adduction as follows. Mitochondrial protein
was standardized to 3 mg/ml in MIB or RIPA buffer (140 mM NaCl,
10 mM Tris–Cl (pH 8.0), 1 mM EDTA, 0.5 mM EGTA, 1% (v/v) Triton
X-100, 0.1% (w/v) sodium deoxycholate, 0.1% (v/v) SDS)þ1X
Complete Protease Inhibitor. Anti-Gstm1 or anti-Prdx6 antibody
was added to a ﬁnal concentration of 1:10 and incubated for 16 h
at 4 1C prior to addition of protein-A agarose beads followed by an
additional 4 h incubation at 4 1C. Both supernatant (immunode-
pleted) and antibody-bound (immunoprecipitated) fractions were
subjected to anti-APAP-adduct Western blot as described above.
Statistical analyses
Datasets were analyzed by ANOVA followed by Student0s t-test
for direct comparison of normally distributed data. Log transfor-
mation of serum ALT activity and APAP metabolites permitted
analysis of the data as a normal distribution. A priori knowledge
that APAP increases serum ALT and histopathology was used to
assess an increase in damage relative to the reference group. For
pairwise comparison of non-normally distributed data, Wilcoxon
rank-sum analysis was conducted. All analyses were conducted
using Prism 6 (GraphPad Software, Inc., La Jolla, CA).
Results
Gclm deﬁciency renders female C57BL/6 mice susceptible to APAP-
induced liver damage
GSH is known to both reduce NAPQI and protect against
oxidative damage. Since GCLM is important for GSH synthesis,
we expected Gclm KO mice to show increased liver damage
after APAP overdose. However, by gender, only female Gclm KO
mice showed a clear enhancement in liver damage induced by
300 mg/kg APAP (Fig. 1A). Regardless of Gclm genotype, all male
mice exhibited a striking elevation in ALT by 6 h after treatment.
Histopathological assessment of liver tissue collected 2 and 6 h
after APAP conﬁrmed centrolobular necrosis in those mice exhi-
biting a marked increase in serum ALT (Fig. 1B, C).
Although we did not observe enhanced liver damage in male
Gclm KO mice relative to male WT mice, APAP treatment was lethal
to 2 of 9 male Gclm KO mice assessed beyond the 6 h time point.
Since we observed peak ALT by 6 h following 300 mg/kg
APAP overdose, we focused upon events that preceded overt liver
damage.
Cytosolic and mitochondrial GSH are similarly depleted in male and
female mice
Gclm KOmice exhibited 5-fold lower liver cytosolic GSH and 2-fold
lower mitochondrial GSH as compared toWT littermates (Fig. 2). APAP
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treatment induced marked but transient depletion of both liver
cytosolic and mitochondrial GSH in all mice within 0.5 h (Fig. 2A).
Male WT and heterozygous (HZ) mice exhibited signiﬁcantly greater
GSH depletion at 1 h and slower replenishment at 6 h compared to
Gclm genotype-matched female mice. However, total hepatic GSH was
replenished in all WT and HZ mice by 12 h post-treatment, although it
remained slightly depleted in Gclm KO mice relative to time zero.
Mitochondrial GSH tracked with cytosolic GSH, and was also slower to
replenish in male GclmWTand HZmice (Fig. 2C). Thus, although there
are subtle differences in GSH, these do not convincingly explain the
enhanced toxicity observed in male Gclm WT and HZ mice compared
to female Gclm WT and HZ mice.
Liver ATP is depleted and ΔΨ is reduced in mice with liver damage
Since APAP is known to impact mitochondrial function,
we hypothesized that mitochondrial function would be more sig-
niﬁcantly impaired in male mice. We therefore measured cytosolic
ATP levels after APAP treatment. Cytosolic ATP levels were variable,
but decreased in all male mice when compared to baseline (Fig. 3A).
As expected, ATP loss was not observed in female Gclm WT or HZ
mice, whereas ATP was depleted in female Gclm KO mice.
In order to help differentiate between loss of ATP due to
metabolic consumption (e.g. GSH synthesis, xenobiotic conju-
gate transporters, etc.), or due to impaired mitochondrial func-
tion, mitochondrial membrane potential (ΔΨ) was quantiﬁed in
fresh, partially fractionated liver homogenate using JC-1 dye
where greaterΔΨ results in more JC-1-aggregates (Em¼590 nm)
relative to JC-1 monomer (Em¼535 nm). In agreement with the
loss of ATP, ΔΨ was lower in male mice compared to female
mice (Fig. 3, Panels B and C). Furthermore, upon addition of
Kreb0s cycle substrates (pyruvate and malate) with a proton
acceptor (NADþ) (PMN), mitochondria isolated from female
mice showed superior polarization compared to those isolated
from male mice.
Furthermore, a follow-up experiment in C57BL/6J male mice
obtained from a commercial vendor (Jackson Laboratory, Bar Harbor,
ME) supported the compiled data generated using in-house Gclm
mice (Fig. 3D–G). Six hours following a dose of 300 mg/kg APAP, ALT
was signiﬁcantly elevated with a slight reduction in GSH. Importantly,
ΔΨ was reduced by 3-fold and ATP levels were diminished.
These results support a mechanism of toxicity whereby male
mice sustain mitochondrial dysfunction, and where loss of Gclm
predisposes female mice to a similar fate.
Fig. 1. APAP overdose induces liver damage in male and Gclm KO mice. Mice were treated with saline or 300 mg/kg APAP. At the indicated times, liver damage was assessed
by (A) measurement of serum alanine aminotransferase activity (ALT) and (B) histopathological scoring of H&E stained parafﬁn-embedded liver tissue (C). (A) Mean of serum
ALT (þSE) at 0, 2, 6, 12, and 24 h following treatment shows sensitivity of male and Gclm KO mice to AILD (nZ4 for each point). (B) Histopathological scoring supports ALT
data (nZ3, except male Gclm KO at 2 h where n¼2). (C) H&E stained liver illustrates centrilobular hepatotoxcity in male and Gclm KO but minimal toxicity in female WT liver
sections 6 h following treatment (bar 200 mm). Pairwise comparisons of log-transformed ALT and untransformed damage score using t-test assuming equal variance;
#po0.05, ##po0.01, ###po0.001, difference by Gclm genotype relative to WT within gender and time; npo0.05, nnpo0.01, difference by gender within Gclm genotype and
time point. Note: APAP treatment was lethal to two male Gclm KO mice, for which ALT values are not reported.
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Speciﬁc adducts are different between male and female mice
Since prior studies have identiﬁed NAPQI adduction of a
number of proteins, we hypothesized that APAP adduction of
cytosolic or mitochondrial proteins would explain the differential
toxicity.
Western blot detection of APAP–Cys protein adducts in
samples collected 1, 2, and 6 h following treatment demonstrated
speciﬁc protein adduction to be Gclm genotype-, gender-, and
time-dependent (Fig. 4, Supplemental Fig. S1). Immunoblots of
cytosol and mitochondria fractions showed more APAP adducts in
Gclm KO mice. Furthermore, while the overall banding was similar
in male and female mice, distinct bands were readily observed
between genders.
In the cytosol, a prominent band of 50 kDa was observed
in both male and female mice within 1 h of treatment (Fig. 4A).
In the mitochondria fraction, a prominent band of 26 kDa was
observed in all male mice within 1 h of treatment, whereas in
female mice the band was less apparent or absent (Fig. 4B). These
gender- and Gclm-dependent band differences persisted for at
least 6 h (Supplemental Fig. S1F).
Identiﬁcation of APAP-adducted 26-kDa mitochondrial protein as
Prdx6
Since male mice showed prominent adduction of a 26-kDa
protein in the mitochondria and ATP was more depleted in male
Gclm WT and HZ mice than in female Gclm WT and HZ mice, we
hypothesized that this protein may be crucial to mitochondrial
function. The protein band was resolved under standard denatur-
ing and reducing conditions in a 12% polyacrylamide gel. Using
LC-MS/MS, a few proteins were identiﬁed in the sample (Table 1).
The top ﬁve ‘hits’ included glutathione-S-transferase mu (Gstm) 1,
Gstm2, Gstm3, peroxiredoxin-6 (Prdx6), and cytochrome c
Fig. 2. Rapid, transient GSH depletion occurs in male and female mice. Total GSH was measured in cytosol (A, B) and mitochondria (C) fractions. APAP overdose induced
rapid but transient depletion of hepatic cytosolic and mitochondrial GSH in all mice (signiﬁcance not indicated). Cytosolic depletion was greater in male Gclm WT and HZ
mice with slower recovery compared to female mice. Gclm KO mice showed signiﬁcantly less GSH in both cytosol and mitochondria fractions. Points and bars represent mean
with SE on bar graphs. #po0.05, ##po0.01, ###po0.001 difference by Gclm genotype; npo0.05, nnpo0.01, nnnpo0.001 difference by gender.
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oxidase, subunit 2 (MT-CO2). Each of these proteins are within the
approximate size of the prominent 26-kDa adduct, and each
contain redox-sensitive cysteine residues. Furthermore, adduction
and inhibition of any or all of these proteins could be reasoned to
result in toxicity.
Mass spectral analysis could not identify any protein-adduct
fragments containing the mass ﬁngerprint of APAP, as we have
previously reported [34]. Western blot analysis of APAP–Cys,
Gstm1, Prdx6, and MT-CO2 illustrated that of these proteins, only
Prdx6 co-migrates at the same molecular weight as the adducted
protein (Fig. 4C, data not shown for MT-CO2). Serial Western blot
analysis for APAP–Cys illustrated the prominent adduct in male
KO mice. Stripping the blot then probing for Gstm1 allowed the
visualization of residual adduct staining with Gstm1 (Fig. 4C, false-
colored red, ﬁlled arrowhead, 23 kDa). Probing this blot
for Prdx6 illustrated the overlap of the adduct of interest with
the Prdx6 band (Fig. 4C, false-colored blue, open arrowhead,
26 kDa). Immunoprecipiation using anti-Prdx6 antibody under
native (MIB) and weakly denaturing conditions (RIPA buffer)
either did not pull-down any protein or resulted in fragmented
banding in both control and immunoprecipitated fractions, respec-
tively (data not shown).
Thus, the combination of protein mass spectral and serial
Western blot yielded the best evidence that the prominent
26-kDa adduct in male mitochondria is Prdx6.
Sub-toxic APAP and N-acetyl-cysteine mitigates Prdx6 adduction
Correlating the dose of APAP with formation of mitochondrial
Prdx6 adduct and ALT illustrates that Prdx6 in mitochondria from
male Gclm HZ mice is extremely sensitive to NAPQI adduction
(Fig. 5A, C). However, at a dose 150 mg/kg APAP, GSH appears
normal, ALT is not elevated and, importantly, the adduction of
Prdx6 is much diminished compared to all higher doses.
N-acetyl-cysteine (NAC) is known to protect against APAP-
induced liver damage. Therefore, we contrasted the adduction of
Prdx6 in male Gclm HZ mice 6 h following 300 mg/kg APAP in
groups that received NAC at 0, 1, 2, and 4 h following APAP, to Gclm
Fig. 3. APAP overdose impairs mitochondria function in male mice. Cytosolic ATP (A) measured at 0, 1, and 2 h illustrates signiﬁcant loss of ATP in male mice (npo0.05,
nnpo0.01, relative to t¼0). Mitochondrial membrane potential (ΔΨ) (B), quantiﬁed by JC-1 uptake, measured in fresh liver homogenate isolated from female and male Gclm
HZ mice 2 h following treatment shows lower basal and less inducible (þPMN) ΔΨ in male mice (n¼3 each). (C) Area under the curve (AUC) relative to APAP-treated male.
Mean (þ/SE) npo0.05, difference by gender; ##po0.01, difference by substrate. Follow-up analysis in male C57BL/6J mice analyzed 6 h following 300 mg/kg APAP
reproduces these effects (D–G) (n¼5, each group). npo0.05, relative to saline by paired t-test, except for ATP analyzed by nonparametric Wilcoxon rank-sum.
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HZ mice receiving APAP alone. NAC mitigated liver damage when
administered prior to 4 h after APAP overdose (Fig. 5D). Further-
more, NAC administration Z1 h following APAP did not reverse
the adduction, even in the absence of signiﬁcantly elevated ALT.
Although NAC enhances GSH replenishment, it should be noted
that 300 mg/kg APAP severely depletes GSH within 30 min (Fig. 2).
These results agree with those of the dose-response, and illustrate
the sensitivity of Prdx6 to adduction by NAPQI. However, the sole
detection of APAP-adducted Prdx6 did not completely predict liver
damage, but had to additionally coincide with sustained GSH
depletion to result in signiﬁcant liver damage.
Enhanced APAP–cysteine formation in female WT and HZ mice
Considering that gender-speciﬁc differences in APAP metabo-
lism have been published, we reasoned that differences in APAP
disposition may contribute to the heightened sensitivity of male
mice to AILD. Thus, we quantiﬁed APAP metabolites at 0.5, 1, 2, and
6 h following dosing, using HPLC-ECD and commercially available
or validated standards.
In all mice, APAP displayed ﬁrst-order elimination from the
liver (Fig. 6A). All mice displayed similar pharmacokinetics for
APAP/APAP–sulfate (Fig. 6A). More APAP–glutathione (APAP–SG)
was present in male Gclm WT and HZ liver homogenate relative to
genotype-matched female mice (Fig. 6B). APAP–SG was much
reduced in Gclm KO mice. APAP–glucuronide (APAP–Gluc) also
peaked higher in male mice relative to genotype-matched female
mice (Fig. 6C). Interestingly, APAP–cysteine peaked 3- to 4-fold
higher in female mice as compared to genotype-matched male
mice (Fig. 6D), and a relatively minor, but easily quantiﬁed
metabolite with a retention time of 15.7 min displayed a stark
gender difference (Fig. 6E). Mass spectrometry identiﬁed this
metabolite as hydroxylated APAP–glutathione (Supplemental
Fig. S2). Lastly, absolute levels of APAP–cysteine protein adducts
were not consistently different between genders within genotype;
however, in agreement with immunoblot data, Gclm KO mice
showed much greater adduct formation in the cytosolic and
mitochondrial fractions (Fig. 6F, Supplemental Fig. S3). Table S1
summarizes the analyzed metabolites and their retention times.
Analysis of the relative area under the curve (AUC) from t¼0.5
to t¼2 h shows that male mice excrete APAP at the same rate as
female mice, but that female GclmWTand HZ mice are much more
efﬁcient at forming APAP–Cys (Fig. 7). The relatively poor conver-
sion of APAP to APAP–Cys observed in male and female Gclm KO
mice suggests decreased hepato-biliary excretion of APAP–SG.
Protein nitration was undetectable
Since protein nitration has been reported in associationwith APAP-
induced liver damage [18,21], we quantiﬁed protein nitration (3-NT,
speciﬁcally) by HPLC-ECD, andWestern blot. 3-NT was not detected by
HPLC-ECD inwhole liver or mitochondrial fractions isolated frommice
within the ﬁrst 6 h following treatment. The limit of detection for 3-
NT by HPLC-ECD was found to be 18 pmol per mg liver (Fig. S4A).
In agreement with ECD, 3-NT Western blot analysis of cytosolic
or mitochondrial liver fractions resolved by SDS-PAGE did not
demonstrate any banding above background in APAP treated
mice. The antibody was validated using peroxynitrite-treated liver
mitochondrial protein (Fig. S4B). Thus, we cannot correlate our
observations with protein nitration (as 3-NT).
Discussion
In this study, we identify two dichotomous molecular biomar-
kers of gender-speciﬁc liver damage induced by APAP in mice:
Fig. 4. Peroxiredoxin-6 adducted in male mitochondria. Cytosolic (A) and mitochondrial (B) APAP-protein adducts were isolated from female and male Gclm WT, HZ, and KO
mice treated at 1 h following treatment. All mice show signiﬁcant protein adduction in cytosolic and mitochondria fractions. Gclm KO mice generally show greater adducts. A
protein of 26-kDa was dichotomously adducted in mitochondria isolated from male mice. Mass spectral analysis of the 26-kDa band identiﬁed a few candidate proteins
(Table 1). (C) Serial Western blot analysis of mitochondria isolated 2 h following treatment demonstrated that peroxiredoxin-6 (Prdx6) (bottom panel of C, blue-shaded open
arrowhead) is the mitochondrial protein that is preferentially adducted in male mice. Cytosolic (25 mg) and mitochondrial (25 mg) proteins were resolved on 12%
polyacrylamide gels under denaturing and reducing and probed as indicated. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Table 1
Peptide fragments identiﬁed in 26-kDa mitochondrial protein fraction.
Protein Coverage (%) Peptides (#) Spectra (#) P MW AA Cys (#)
Gstm1 72.5 37 167 1 25,971 218 2
Gstm2 64.2 14 23 1 25,718 218 3
Prdx6 62.5 17 39 1 24,827 224 2
Gstm3 55.5 13 21 1 25,702 218 4
MT-CO2 53.7 32 62 1 25,947 227 3
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adduction of Prdx6 and increased formation of APAP-(OH)–SG.
These biomarkers precede classical markers of damage and were
identiﬁed by toxico/pharmacokinetic analysis of mice with differ-
ential susceptibility to AILD – male and female mice on the C57BL/
6J inbred background that are either WT, HZ, or KO for Gclm.
From these observations, we propose a model of acetaminophen-
induced liver damage wherein protein arylation of Prdx6 by NAPQI
predisposes hepatocellular death during the coincident depletion
of intrahepatic GSH. Under these conditions, there is poor hepato-
biliary excretion of APAP–SG allowing further oxidation of
APAP–SG to APAP–(OH)–SG. No single mechanism is sufﬁcient to
account for the differential susceptibility between gender and
Gclm deﬁciency.
As previously shown, gender and Gclm deﬁciency were observed
to be determinants of the severity of AILD in mice [27]. Female mice
were highly resistant to the hepatotoxic effects of APAP. However,
genetic deletion of Gclm, and therefore deﬁciency in GSH, predis-
posed female mice to AILD and further increased the sensitivity of
male mice as reﬂected in the death of 2 male Gclm KOmice observed
beyond 6 h. It is clear that protein arylation is necessary for APAP to
cause liver damage in mice [39]. The increased sensitivity of Gclm KO
mice to AILD supports this conclusion. However, in regards to
gender-speciﬁc susceptibility, bulk protein arylation of total liver or
mitochondria protein cannot explain the resistance of female mice to
AILD [12]. Together, these observations support a compounding
mechanism of toxicity whereby NAPQI-protein adduction is neces-
sary but not sufﬁcient to induce liver damage.
One of the earliest indicators of toxicity is loss of ATP prior to
elevated serum ALT. APAP-induced ATP depletion and loss of
mitochondrial ΔΨ has been reported previously [24,30], but the
present study is the ﬁrst comparison of APAP-induced mitochon-
drial dysfunction in male and female mice. The early loss of ATP in
male and female Gclm KO mice supports a mechanism of toxicity
where disruption of mitochondrial function in association with
protein adduction, and suggests that adduction of speciﬁc mito-
chondrial protein(s) impairs ATP synthesis. Furthermore, GSH
synthesis is dependent upon ATP [7]. This culminates in a feed-
forward toxicity whereby bioactivation of APAP results in GSH
depletion that permits greater protein adduction, which then
initiates mitochondrial dysfunction, loss of ATP, and the inability
to resynthesize GSH. However, this model still fails to explain why
female mice resist APAP-induced mitochondrial dysfunction.
Through our Western immunoblot analysis of arylation of mito-
chondrial proteins we observed a few stark differences between
susceptible and resistant mice. Firstly, the intensity of arylation is
higher in Gclm KO mice, which was expected and supported by
absolute quantiﬁcation. Secondly, and more intriguingly, the aryla-
tion pattern between male and female mice is noticeably different,
and proteomic analysis shows that male mice are predisposed to
arylation of mitochondria-associated 26-kDa protein. APAP adduction
of Gstm, Prdx6, and MT-CO2 has not been reported, but cysteine
adduction of any or all of these enzymes could clearly impact
mitochondrial function and therefore ATP synthesis. However, of
these candidates, only Prdx6 co-migrated with the APAP-adducted
band.
Peroxiredoxin-6, an atypical 1-Cys peroxiredoxin, is dependent
upon GSH for reduction of its active site cysteine [see review by
[25]]. Although adduction of Prdx6 by APAP has not been reported,
Fig. 5. Prdx6 protein is extremely sensitive to adduction. Dose-response in male Gclm HZ mice illustrated the sensitivity of mitochondrial Prdx6 to adduction by APAP (A, B).
The degree of Prdx6 adduction is diminished at 6 h following treatment with 150 mg/kg APAP (A), which does not induce sustained GSH depletion or elevated ALT (B).
Furthermore, N-acetyl-cysteine (NAC) administration at indicated times following 300 mg/kg APAP reduces Prdx6 adduction, total protein arylation (C) and mitigates toxicity
(D). Mean (SE); for dose response nZ4, for NAC rescue nZ3 except for AþNAC (0 h) where n¼2. Pairwise comparisons of log-transformed ALT and untransformed GSH
using t-test; npo0.05, nnpo0.01, nnnpo0.001, nnnnpo0.0001 relative to saline control.
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proteomic analysis of Gstp1/2 KO mice, which are highly resistant
to AILD, revealed that Prdx6 (anti-oxidant protein-2 (AOP2) or 1-
Cys peroxiredoxin) was one of the most highly induced proteins
compared to AILD susceptible wild-type mice [17,23]. Peroxire-
doxins are induced by oxidative stress [25]; an observation that is
consistent with ‘autoprotection’ whereby sub-toxic APAP protects
against AILD [1]. Furthermore, peroxiredoxin-6 has seen been
shown to play an important role in regulating stress-induced cell
death in both retinal ganglion cells [36] and keratinocytes [33],
and translocates to mitochondria under conditions of oxidative
stress associated with hypoxia/reperfusion injury in the liver [13].
Taken together, our data suggest that arylation of peroxiredoxin-6
compromises its protective function(s) in mitochondria and pre-
disposes male mice to AILD.
Our follow-up study using sub-toxic doses of APAP and
NAC-mediated protection in male mice illustrated that Prdx6 is
extremely sensitive to arylation, and that decreased arylation was
observed when sub-toxic doses of APAP were administered or
when NAC was administered together with APAP. However, due to
the presence of Prdx6 adduction in the absence of overt toxicity,
such as NAC administration 1 h following APAP, we investigated
the potential interaction between adduction and metabolism.
Our metabolite analysis showed that, like protein arylation,
male and female mice metabolize APAP differently, as do Gclm WT
and Gclm KO mice. These differences highlight a few key metabolic
indicators that are predictive of acute toxicity: intrahepatic accu-
mulation of APAP–glucuronide, APAP–SG, and APAP–(OH)–SG, and
greater protein adduction in Gclm KO mice.
Enhanced excretion of APAP–glucuronide is associated with
repeated APAP dosing in humans; whether this is protective or an
indication of toxicity is unclear [15]. While APAP–glucuronide
is not inherently toxic, increased levels may indicate oxidative
stress that biases UDP–glucuronide formation and UGT activity [5].
Alternatively or in combination, less APAP–glucuronide may
reﬂect increased basal expression of multi-drug resistance asso-
ciated protein 4 (Mrp4) in female mice that could hasten the
Fig. 6. Gender-speciﬁc metabolism of APAP. Previously frozen liver was analyzed for metabolites of APAP by HPLC-ECD: (A) APAPþAPAP–SO4, (B) APAP–glutathione (APAP–
SG), (C) APAP–glucuronide (APAP–Gluc), (D) APAP–cysteine (APAP–Cys), (E) APAP–(OH)–SG, and (F) APAP–Cys adducts. Overall, male and female mice metabolize APAP
distinctly, with differences in most major metabolites. No difference in absolute APAP–Cys adducts was observed between genders. Geometric mean values (pmol/mg liver)
are indicated (nZ4). ANOVA performed on log-transformed data was used to determine differences within a metabolite, followed by pairwise comparison using t-test
assuming equal variance. npo0.05, nnpo0.01, nnnpo0.001, difference by gender within Gclm genotype and time.
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overall excretion of APAP and metabolites from the liver [2,26].
Mrp4 induction is less likely the case in our study, due to the
observation that early clearance of APAP from the liver neither
differs between male and female mice nor between Gclm WT and
Gclm KO mice. Instead, our data suggest that female mice display
greater hepato-biliary excretion of APAP–SG. This would allow
more rapid conversion of APAP–SG to APAP–Cys in the kidney and
elimination in the urine [14].
Thus, although we observe clear gender-speciﬁc differences
in metabolism, only the substantial increase in protein adducts
present in Gclm KO mice can be easily rationalized and has
precedence for increasing toxicity.
These data lead us to a model in which parallel depletion of
GSH and arylation of a mitochondrial Prdx6 results in heightened
sensitivity of male mice to APAP-induced centrilobular necrosis.
This does not exclude other mechanisms of death, as illustrated in
female Gclm KO mice, which show both less APAP–Cys metabolite
and ATP depletion, but with no apparent adduction of Prdx6.
Importantly, NAC treatment subverts toxicity in WT and HZ
male mice by augmenting GSH synthesis, mitigating further
protein arylation, and perhaps rectifying mitochondrial stress
[27]. Furthermore, considering the comparable expression of
Prdx6 in male and female mice, at present we cannot explain
why Prdx6 is preferentially adducted in male mice. It is intriguing
to propose the differential formation of the ipso adduct [6], which
may account for the increased APAP–SG levels and formation
of APAP–(OH)–SG in male mice and allow for the differences in
protein adduction. Under the HPLC separation conditions, APAP–
SG isomers would be indistinguishable and quantiﬁed as one
metabolite.
In summary, male mice are the preferred rodent model to
understand APAP metabolism and toxicity. In this study, we
leveraged the observation that female mice on the C57BL/6 back-
ground are resistant to liver damage, in order to identify several
molecular events associated with toxicity. The results reinforce a
multifactorial mechanism of liver damage dependent upon: GSH
depletion, protein arylation and mitochondrial dysfunction. We
introduce the hypothesis that APAP adduction of peroxiredoxin-6
is an important factor underlying the sensitivity of male mice to
AILD. Although gender-speciﬁc differences in AILD are observed in
mice, the relevance of these ﬁndings to humans is not deﬁned.
Nonetheless, consideration of these factors in human APAP over-
dose appears warranted.
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